Government and Regulations

Ensuring the Treatment Fits the Patient

Dr. Richard Weinshilboum of the Mayo Clinic talks about using genomic information to tailor patient treatments.



Richard Weinshilboum, MD, has established a research program at the Mayo Clinic that uses genomic techniques, including genomewide association studies and whole genome DNA sequencing, which uses samples from large numbers of patients treated with a specific anticancer or antidepressant drug. He sat down with Federal Practitioner to discuss the role genetic testing plays in personalized medicine.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Individualized therapy: 1:11

Common genetic variations: 2:41

Using genomics for preemptive treatment: 6:06

Privacy concerns: 7:44

Cost effectiveness: 8:43

Applying genomics: 10:06

Recommended Reading

Woodson Steps Down at DoD
Federal Practitioner
Aprepitant Protects Against Chemo-Induced Nausea and Vomiting
Federal Practitioner
SAMHSA Reports Track Behavioral Health in U.S.
Federal Practitioner
Grants Available for Native American Mental Health Programs
Federal Practitioner
Winning Ideas for Preventing and Reducing VTE
Federal Practitioner

Related Articles